MGMT and glioblastoma: To further define the role of MGMT on radioresponse, MGMT was exogenously added to non-MGMT-producing cells (GBM [OSU61], GSCs [NSC11] and melanoma cells [WM852 and WM266-4]) and assessed using a clonogenic cell survival assay.